No Data
No Data
No Data
7 Days 6 Boards, lbx pharmacy chain joint stock (603883.SH): There have been no significant changes in operation, please beware of speculative trading in the market.
lbx pharmacy chain joint stock (603883.SH) has announced that on September 9, 2024, the company's stocks closed at the limit-up price, stocks...
LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Shares Bounce 30% But Its Business Still Trails The Market
Geelong Announcement Selection │ Cecep Wind-Power Corporation: Planning to invest 1.523 billion yuan in constructing the CECEP Mulan 200MW wind power + clean heating project; Yifei Laser: Shareholders Yipo New Energy, Haifu Yangtze River, and Zhongbi Fund
[Business Data] Shenzhen Kingkey Smart Agriculture Times (000048.SZ): The sales revenue of hog sales in August was 0.445 billion yuan; China Vanke Co., Ltd. (000002.SZ): The contract sales amount in August was 17.24 billion yuan; Suning Bang Technology Co., Ltd. (002157.SZ): The sales revenue of hog sales in August was 0.456 billion yuan; Wens Foodstuff Group (300498.SZ): The sales revenue of pork sales in August was 5.863 billion yuan; Jiangsu Lihua Animal Husbandry (300761.SZ): The sales revenue of broilers in August was 1.31 billion yuan, and the sales revenue of pork was 0.251 billion yuan; Seazen Holdings (601155.SH): The realized contract sales amount in August was about 25 billion yuan.
lbx pharmacy chain joint stock (603883.SH): We have not received any investigation or cooperation documents from the competent authorities regarding the company.
lbx pharmacy chain joint stock (603883.SH) issued a stock price abnormal movement announcement, stating that the company disclosed "..." on July 31, 2024.
3 consecutive boards lbx pharmacy chain joint stock (603883.SH): There are no significant matters that should be disclosed but have not been disclosed.
Lbx pharmacy chain joint stock (603883.SH) announced that the company's stocks closed at the limit price for three consecutive trading days on September 3, 4, and 5, 2024. The stock price has recently seen a significant increase, with a larger increase than most companies in the pharmaceutical retail industry. The stock price has large fluctuations and carries the risk of market overheating, with the possibility of a decline after a significant increase in the short term. As of the date of this announcement, there have been no significant changes in the company's main business, production and operation, and operating environment compared to the information previously disclosed, and there are no major matters that should be disclosed but have not been disclosed by the company.
lbx pharmacy chain joint stock (603883.SH): There have been no major changes in asset structure and main business.
On September 4th, Lbx Pharmacy Chain Joint Stock (603883.SH) announced the abnormal stock trading volatility. After the company's self-inspection, the company's production and operation are currently normal, and there have been no significant changes in asset structure and main business. There is no significant change in the internal and external operating environment that has occurred or is expected to occur. After the company's self-inspection and verification through written letters to the company's controlling shareholder, Medicine Group, and one of the actual controllers, Ms. Chen Xiulan (one of the actual controllers, Mr. Xie Zilong, is in custody and under investigation. His written confirmation has not been obtained), as of the date of this announcement, there are no significant matters affecting the abnormal stock trading volatility of the company's shares.
No Data